Lin BioScience, Inc. (TPEX:6696)
Taiwan · Delayed Price · Currency is TWD 174.50
+1.50 (0.87%)
Oct 8, 2026, 1:59 PM CST
Lin BioScience Market Cap
Lin BioScience has a market cap or net worth of 104.13 billion as of October 8, 2026. It is the 3,923rd most valuable company in the world and the 115th biggest in Taiwan. Its market cap has increased by 674.58% in one year.
Market Cap
104.13B
Enterprise Value
103.77B
Revenue
n/a
Global Rank
Country Rank
#115 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 8, 2018, Lin BioScience's market cap has increased from 2.92B to 104.13B, an increase of 3,470.70%. That is a compound annual growth rate of 56.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 143.45B | 336.80% |
| Dec 31, 2025 | 32.84B | 203.76% |
| Dec 31, 2024 | 10.81B | 20.85% |
| Dec 29, 2023 | 8.95B | -28.90% |
| Dec 30, 2022 | 12.58B | -1.94% |
| Dec 30, 2021 | 12.83B | 83.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 122.57B |
| Pell Bio-Med Technology | 62.38B |
| CHO Pharma | 25.79B |
| Oneness Biotech | 22.58B |
| Sunmax Biotechnology | 21.51B |
| Medigen Vaccine Biologics | 19.86B |
| Steminent Biotherapeutics | 17.36B |
| TaiMed Biologics | 16.39B |